Thomas Thomas T.'s Form 4 filing
Opiant Pharmaceuticals, Inc. (OPNT) · filed Sep 23, 2021
- Accession no.
- 0001385508-21-000138
- Filed
- Sep 23, 2021
- Trade date
- Sep 21-22, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $38.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thomas Thomas T.CIK 0001689819 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 | Common Stock | MOption exerciseAcquired | +2,000 | $10.00 | +$20,000 | 10,107 | Direct | |
| Sep 21, 2021 | Common Stock | SSaleDisposed | −60 | $24.07 | −$1,444.2 | 10,047 | Direct | |
| Sep 21, 2021 | Common Stock | SSaleDisposed | −771 | $24.12 | −$18,596.52 | 9,276 | Direct | |
| Sep 22, 2021 | Common Stock | MOption exerciseAcquired | +1,834 | $10.00 | +$18,340 | 11,110 | Direct | |
| Sep 22, 2021 | Common Stock | SSaleDisposed | −735 | $25.02F5 | −$18,389.7 | 10,375 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2021 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 1,834 | Direct | |
| Sep 22, 2021 | Common Stock | MOption exerciseDisposed | −1,834 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F5
This transaction was executed in multiple trades at prices ranging from $24.52 to $25.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.